A Risk Sciences International news item posted on March 16, 2021 and last updated on March 24, 2021

Dr. Donald Mattison, RSI’s Senior Vice-President and Chief Medical Officer, has accepted an appointment as a University of South Carolina Health Sciences Distinguished Professor in the in the Arnold School of Public Health (ASPH).  The appointment noted that Dr. Mattison’s broad and deep career experience as a researcher and educator is impressive and valuable to USC.  Dr Mattison’s academic home within ASPH will be in the Department of Epidemiology and Biostatistics. Dr Mattison anticipates continuing research on structure activity relationships in reproductive and developmental toxicology, drug and vaccine efficacy and safety, as well as other work with RSI.

The entire RSI family congratulates Dr. Mattison for his appointment.

Read Dr. Mattison’s bio here.

More RSI News

IAI climate change report

April 12, 2022

The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and…

Quinolones and risk of acute liver failure

April 12, 2022

Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…

RSI launches Global Risk Census

March 1, 2022

Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be…

US FDA FAERS and quinolones

June 22, 2021

Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised…